Dwarfism Clinical Trial
Official title:
Phase 2 Study of Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS (Idiopathic Short Stature): a 52-week Multicenter, Open-label, Randomized, Negative Controlled Study Followed by a 52-week Open-label Period
Phase 1: To evaluate the safety and efficacy of 0.05mg/kg/d of rhGH (Jintropin®) in the
treatment of children with idiopathic short stature (ISS) in 52 weeks.
Phase 2: To evaluate the safety and efficacy of rhGH (Jintropin®) in the treatment of
children with ISS in 2 years
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01157793 -
A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood
|
Phase 4 | |
| Completed |
NCT00001190 -
Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature
|
Phase 2 | |
| Active, not recruiting |
NCT03255694 -
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
|
Phase 2 | |
| Recruiting |
NCT03535415 -
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
|
Phase 3 | |
| Recruiting |
NCT03221088 -
A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature
|
Phase 2 | |
| Completed |
NCT00234533 -
Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
|
Phase 3 | |
| Completed |
NCT00001754 -
Study of Skeletal Disorders and Short Stature
|
N/A | |
| Completed |
NCT00001343 -
The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome
|
Phase 2 | |
| Completed |
NCT00001536 -
Issues Surrounding Prenatal Genetic Testing for Achondroplasia
|
N/A |